Table 1.

Dose and duration of IL-2 therapy

Patient no.
Diagnosis
Age, y
IL-2 dose, U/m2 per d
Duration of IL-2 therapy when tested, wk
After IL-2 testing, wk
1   Renal cell carcinoma   66   1 × 106  9   NA  
2   Renal cell carcinoma   42   3-6 × 105  10   NA  
3   Renal cell carcinoma   53   1-1.5 × 106  10   NA  
4   Renal cell carcinoma   56   6 × 105  11   NA  
5   Renal cell carcinoma   58   6 × 105  8   NA  
6   Lung sarcoma   23   1.5 × 105  8   NA  
7   Renal cell carcinoma   67   1-1.5 × 106  10   19  
8   Rectal cancer   42   6 × 105  8   NA  
9   NSCL carcinoma   31   6 × 105  6.5   45  
10   Colon cancer   62   6 × 105  10   NA  
11   Renal cell carcinoma   60   0.6-1.25 × 106  9   17  
12   Melanoma   41   4.5-6 × 105  10   19  
13   CML (chronic phase)   38   2-4 × 105  11   19.5  
14   CML (chronic phase)   44   4 × 105  4   17  
15   CML (chronic phase)   44   2-4 × 105  4   NA  
16   CML (chronic phase)   49   2-4 × 105  9   20  
17   CML (chronic phase)   41   3-4 × 105  5   NA  
18   CML (accelerated phase)   24   4 × 105  5   38  
19   CML (chronic phase)   33   2-4 × 105  4   NA  
20   CML (chronic phase)   49   2-4 × 105  5   17  
21
 		 CML (chronic phase)
 		 29
 		 2-4 × 105
 		 5.5
 		 21
 
Patient no.
Diagnosis
Age, y
IL-2 dose, U/m2 per d
Duration of IL-2 therapy when tested, wk
After IL-2 testing, wk
1   Renal cell carcinoma   66   1 × 106  9   NA  
2   Renal cell carcinoma   42   3-6 × 105  10   NA  
3   Renal cell carcinoma   53   1-1.5 × 106  10   NA  
4   Renal cell carcinoma   56   6 × 105  11   NA  
5   Renal cell carcinoma   58   6 × 105  8   NA  
6   Lung sarcoma   23   1.5 × 105  8   NA  
7   Renal cell carcinoma   67   1-1.5 × 106  10   19  
8   Rectal cancer   42   6 × 105  8   NA  
9   NSCL carcinoma   31   6 × 105  6.5   45  
10   Colon cancer   62   6 × 105  10   NA  
11   Renal cell carcinoma   60   0.6-1.25 × 106  9   17  
12   Melanoma   41   4.5-6 × 105  10   19  
13   CML (chronic phase)   38   2-4 × 105  11   19.5  
14   CML (chronic phase)   44   4 × 105  4   17  
15   CML (chronic phase)   44   2-4 × 105  4   NA  
16   CML (chronic phase)   49   2-4 × 105  9   20  
17   CML (chronic phase)   41   3-4 × 105  5   NA  
18   CML (accelerated phase)   24   4 × 105  5   38  
19   CML (chronic phase)   33   2-4 × 105  4   NA  
20   CML (chronic phase)   49   2-4 × 105  5   17  
21
 		 CML (chronic phase)
 		 29
 		 2-4 × 105
 		 5.5
 		 21
 

NA indicates not applicable

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal